NASDAQ:BVXV
BiondVax Pharmaceuticals Ltd.
- Stock
Last Close
1.35
06/09 19:59
Market Cap
4.97M
Beta: 2.47
Volume Today
22.67K
Avg: 41.50K
PE Ratio
0.59
PFCF: −3.53
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 25.50K - | 25.50K 0% | -291K 1,241.18% | -291K 0% | ||||||
average payables | 458K - | 727.50K 58.84% | 808.50K 11.13% | 3.45M 327.27% | 5.86M 69.71% | 11.28M 92.44% | 8.82M 21.81% | 1.84M 79.10% | 1.91M 3.66% | |
average receivables | 752K - | 1.22M 62.63% | 1.08M 11.41% | 1.97M 81.68% | 1.71M 12.90% | 302.61K 82.35% | 361.72K 19.53% | 340.22K 5.94% | 208K 38.86% | |
book value per share | 50.76 - | 127.16 150.48% | 75.84 40.35% | 111.93 47.57% | -12.68 111.33% | -79.66 528.15% | -4.10 94.86% | 16.53 503.58% | -0.93 105.65% | |
capex per share | -0.09 - | -0.13 40.37% | -0.06 54.05% | -8.97 15,047.38% | -36.31 304.81% | -9.10 74.95% | -5.53 39.17% | -0.30 94.49% | -0.44 45.56% | |
capex to depreciation | -0.04 - | -0.05 22.18% | -0.03 40.51% | -10.25 31,712.14% | -91.27 790.86% | -4.52 95.05% | -2.52 44.26% | -0.18 92.93% | -1.49 735.45% | |
capex to operating cash flow | 0.00 - | 0.00 16.42% | 0.00 37.43% | 0.45 21,549.61% | 0.41 7.50% | 0.10 76.77% | 0.08 12.32% | 0.02 79.22% | 0.12 555.22% | |
capex to revenue | -0.16 - | |||||||||
cash per share | 35.59 - | 134.52 277.98% | 52.47 60.99% | 142.03 170.68% | 30.83 78.29% | 88.74 187.84% | 2.64 97.02% | 38.28 1,348.03% | 7.47 80.50% | |
days of inventory on hand | ||||||||||
days payables outstanding | ||||||||||
days sales outstanding | 40.64 - | |||||||||
debt to assets | 0.89 - | 1.13 27.21% | 1.18 4.05% | 0.70 40.67% | 0.80 13.67% | |||||
debt to equity | -3.02 - | -2.02 33.24% | -4.60 128.01% | 2.99 164.95% | -12.24 509.53% | |||||
dividend yield | ||||||||||
earnings yield | -0.12 - | -0.25 105.03% | -0.21 15.74% | -0.36 70.02% | -0.20 44.67% | -0.47 138.12% | 0.07 114.40% | -0.49 824.51% | -0.10 80.72% | |
enterprise value | 53.92M - | 7.24M 86.58% | 27.80M 284.18% | 24.88M 10.50% | 122.20M 391.16% | 321.28M 162.91% | 118.01M 63.27% | 118.66M 0.55% | 13.05M 89.00% | |
enterprise value over ebitda | -7.22 - | -0.68 90.62% | -2.46 263.61% | -2.02 17.95% | -6.21 207.00% | -4.18 32.67% | 33.95 912.22% | -3.66 110.77% | -1.24 66.02% | |
ev to operating cash flow | -7.12 - | -0.70 90.10% | -2.88 308.62% | -2.48 14.03% | -2.14 13.69% | -4.17 95.13% | -1.63 60.98% | -4.85 197.90% | -1.80 62.95% | |
ev to sales | 43.18 - | |||||||||
free cash flow per share | -23.27 - | -39.05 67.83% | -28.64 26.65% | -28.97 1.14% | -123.82 327.46% | -103.46 16.45% | -70.99 31.38% | -17.65 75.14% | -4.30 75.66% | |
free cash flow yield | -0.12 - | -0.25 111.49% | -0.22 12.14% | -0.15 31.98% | -0.69 356.19% | -0.32 53.34% | -0.79 144.25% | -0.24 69.23% | -1.45 499.97% | |
graham net net | 32.24 - | 109.08 238.31% | 40.94 62.47% | 96.14 134.85% | -25.00 126.01% | -132.34 429.31% | -17.17 87.03% | -15.59 9.22% | -7.78 50.08% | |
graham number | 164.74 - | 332.58 101.88% | 215.42 35.23% | 416.09 93.16% | 100.85 75.76% | 521.92 417.55% | 23.81 95.44% | 115.71 386.04% | 2.43 97.90% | |
income quality | 0.98 - | 1.01 3.22% | 1.05 4.41% | 0.29 72.33% | 0.65 124.13% | 0.71 8.25% | 16.28 2,207.30% | 0.61 96.24% | 1.25 104.67% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -5.67 - | -5.25 7.34% | 0.21 104.07% | -3.22 1,603.11% | 2.10 165.34% | |||||
interest debt per share | 43.86 - | 179.03 308.19% | 23.24 87.02% | 57.08 145.67% | 8.63 84.87% | |||||
inventory turnover | ||||||||||
invested capital | -3.02 - | -2.02 33.24% | -4.60 128.01% | 2.99 164.95% | -12.24 509.53% | |||||
market cap | 63.53M - | 40.71M 35.93% | 43.50M 6.87% | 96.26M 121.28% | 117.30M 21.85% | 262.46M 123.76% | 100.06M 61.88% | 102.96M 2.90% | 5.58M 94.58% | |
net current asset value | 10.83M - | 29.17M 169.21% | 21.64M 25.79% | 49.86M 130.36% | -15.99M 132.06% | -107.68M 573.62% | -18.93M 82.42% | -21.22M 12.07% | -14.46M 31.86% | |
net debt to ebitda | 1.29 - | 3.14 143.50% | 1.39 55.59% | 5.80 316.69% | -0.25 104.30% | -0.77 207.03% | 5.17 775.09% | -0.48 109.37% | -0.71 46.96% | |
net income per share | -23.76 - | -38.66 62.70% | -27.19 29.66% | -68.75 152.82% | -35.64 48.16% | -151.98 326.42% | 6.15 104.05% | -36.00 685.34% | -0.28 99.22% | |
operating cash flow per share | -23.17 - | -38.92 67.94% | -28.58 26.56% | -20.00 30.03% | -87.51 337.62% | -94.36 7.83% | -65.46 30.63% | -17.35 73.50% | -3.85 77.78% | |
payables turnover | ||||||||||
receivables turnover | 8.98 - | |||||||||
research and ddevelopement to revenue | 3.76 - | |||||||||
return on tangible assets | -0.42 - | -0.25 41.29% | -0.31 23.53% | -0.42 38.66% | -0.83 95.99% | -1.07 29.36% | 0.39 135.91% | -0.51 232.48% | -0.02 96.15% | |
revenue per share | 1.95 - | |||||||||
roe | -0.47 - | -0.30 35.05% | -0.36 17.92% | -0.61 71.32% | 2.81 557.56% | 1.91 32.11% | -1.50 178.70% | -2.18 45.04% | 0.30 113.85% | |
roic | -0.49 - | -0.34 31.43% | -0.46 37.19% | -0.55 19.79% | -1.37 147.97% | -1.21 11.94% | -0.28 77.04% | -0.44 60.32% | -0.05 89.27% | |
sales general and administrative to revenue | 8.73 - | |||||||||
shareholders equity per share | 50.76 - | 127.16 150.48% | 75.84 40.35% | 111.93 47.57% | -12.68 111.33% | -79.66 528.15% | -4.10 94.86% | 16.53 503.58% | -0.93 105.65% | |
stock based compensation to revenue | 3.24 - | |||||||||
tangible asset value | 16.59M - | 33.55M 102.24% | 25.62M 23.64% | 56.25M 119.60% | -8.29M 114.73% | -65.05M 684.89% | -4.54M 93.02% | 23.33M 614.03% | -1.76M 107.54% | |
tangible book value per share | 50.76 - | 127.16 150.48% | 75.84 40.35% | 111.93 47.57% | -12.68 111.33% | -79.66 528.15% | -4.10 94.86% | 16.53 503.58% | -0.93 105.65% | |
working capital | 10.90M - | 35.23M 223.32% | 24.76M 29.71% | 68.42M 176.30% | 14.62M 78.64% | 54.16M 270.57% | -16.66M 130.75% | 47.84M 387.20% | 12.03M 74.85% |
All numbers in USD (except ratios and percentages)